J Korean Diabetes > Volume 11(2); 2010 > Article
The Journal of Korean Diabetes 2010;11(2):130-136.
DOI: https://doi.org/10.4093/kcd.2010.11.2.130   
당뇨병에서의 이상지질혈증의 관리
Management of Dyslipidemia in Type 2 Diabetes Mellitus
Suk Kyeong Kim
Dyslipidemia commonly associated with type 2 diabetes includes elevated triglycerides, low levels of high-density lipoprotein (HDL) cholesterol, and preponderance of small dense low-density lipoprotein (LDL) particles, with LDL cholesterol generally being similar to that of non-diabetic patients. The cornerstone of treatment for diabetic dyslipidemia is therapeutic lifestyle change. In addition to these measures, recent clinical trials have demonstrated the benefits of 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor (statins) therapy. Although drug therapy for dyslipidemia must be individualized, most people with diabetes mellitus are candidates for statin therapy and often need to be treated with multiple agents to achieve therapeutic goals. (Korean Clinical Diabetes J 11:130-136, 2010)
Key Words: Cardiovascular disease, Dyslipidemia, Statin, Type 2 DM

Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2024 by Korean Diabetes Association. All rights reserved.

Developed in M2PI

Close layer